194 related articles for article (PubMed ID: 33239678)
21. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
22. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
[TBL] [Abstract][Full Text] [Related]
23. Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway.
Chen K; Liu Q; Tsang LL; Ye Q; Chan HC; Sun Y; Jiang X
Cell Death Dis; 2017 May; 8(5):e2819. PubMed ID: 28542126
[TBL] [Abstract][Full Text] [Related]
24. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
[TBL] [Abstract][Full Text] [Related]
25. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail.
Feng J; Cen J; Li J; Zhao R; Zhu C; Wang Z; Xie J; Tang W
Cell Adh Migr; 2015; 9(6):495-501. PubMed ID: 26632346
[TBL] [Abstract][Full Text] [Related]
27. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
Zheng H; Li W; Wang Y; Liu Z; Cai Y; Xie T; Shi M; Wang Z; Jiang B
Eur J Cancer; 2013 Aug; 49(12):2734-46. PubMed ID: 23582741
[TBL] [Abstract][Full Text] [Related]
29. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
30. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
Wang F; Ruan XJ; Zhang HY
Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
[TBL] [Abstract][Full Text] [Related]
31. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
32. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
Geng F; Jiang Z; Song X; Zhou H; Zhao H
Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
[TBL] [Abstract][Full Text] [Related]
33. Chemopreventive activity of GEN-27, a genistein derivative, in colitis-associated cancer is mediated by p65-CDX2-β-catenin axis.
Du Q; Wang Y; Liu C; Wang H; Fan H; Li Y; Wang J; Zhang X; Lu J; Ji H; Hu R
Oncotarget; 2016 Apr; 7(14):17870-84. PubMed ID: 26910375
[TBL] [Abstract][Full Text] [Related]
34. AIF inhibits tumor metastasis by protecting PTEN from oxidation.
Shen SM; Guo M; Xiong Z; Yu Y; Zhao XY; Zhang FF; Chen GQ
EMBO Rep; 2015 Nov; 16(11):1563-80. PubMed ID: 26415504
[TBL] [Abstract][Full Text] [Related]
35. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
Tao L; Zhu Y; Gu Y; Zheng J; Yang J
Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
[TBL] [Abstract][Full Text] [Related]
36. Reduced Caudal Type Homeobox 2 (CDX2) Promoter Methylation Is Associated with Curcumin's Suppressive Effects on Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Chen T; Yang C; Xi Z; Chen F; Li H
Med Sci Monit; 2020 Sep; 26():e926443. PubMed ID: 32893845
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
[TBL] [Abstract][Full Text] [Related]
38. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
[TBL] [Abstract][Full Text] [Related]
39. LIN28B induces a differentiation program through CDX2 in colon cancer.
Suzuki K; Masuike Y; Mizuno R; Sachdeva UM; Chatterji P; Andres SF; Sun W; Klein-Szanto AJ; Besharati S; Remotti HE; Verzi MP; Rustgi AK
JCI Insight; 2021 May; 6(9):. PubMed ID: 33755595
[TBL] [Abstract][Full Text] [Related]
40. miR-221 Promotes Epithelial-Mesenchymal Transition through Targeting PTEN and Forms a Positive Feedback Loop with β-catenin/c-Jun Signaling Pathway in Extra-Hepatic Cholangiocarcinoma.
Li J; Yao L; Li G; Ma D; Sun C; Gao S; Zhang P; Gao F
PLoS One; 2015; 10(10):e0141168. PubMed ID: 26501139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
